Adaptive design improvements in the continual reassessment method for phase I studies
- 1 June 1999
- journal article
- research article
- Published by Wiley in Statistics in Medicine
- Vol. 18 (11) , 1307-1321
- https://doi.org/10.1002/(sici)1097-0258(19990615)18:11<1307::aid-sim128>3.0.co;2-x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Miscellanea. A stopping rule for the continual reassessment methodBiometrika, 1998
- IMPROVED DESIGNS FOR DOSE ESCALATION STUDIES USING PHARMACOKINETIC MEASUREMENTSStatistics in Medicine, 1996
- Consistency of continual reassessment method under model misspecificationBiometrika, 1996
- Some practical improvements in the continual reassessment method for phase I studiesStatistics in Medicine, 1995
- A comparison of two phase I trial designsStatistics in Medicine, 1994
- Statistical and Ethical Issues in the Design and Conduct of Phase I and II Clinical Trials of New Anticancer AgentsJNCI Journal of the National Cancer Institute, 1993
- The continual reassessment method in cancer phase i clinical trials: A simulation studyStatistics in Medicine, 1993
- Model-Guided Determination of Maximum Tolerated Dose in Phase I Clinical Trials: Evidence for Increased PrecisionJNCI Journal of the National Cancer Institute, 1993
- Methods for dose finding studies in cancer clinical trials: A review and results of a monte carlo studyStatistics in Medicine, 1991